Reduced N-Type Ca Channels in Atrioventricular Ganglion Neurons Are Involved in Ventricular Arrhythmogenesis
Overview
Affiliations
Background: Attenuated cardiac vagal activity is associated with ventricular arrhythmogenesis and related mortality in patients with chronic heart failure. Our recent study has shown that expression of N-type Ca channel α-subunits (Ca2.2-α) and N-type Ca currents are reduced in intracardiac ganglion neurons from rats with chronic heart failure. Rat intracardiac ganglia are divided into the atrioventricular ganglion (AVG) and sinoatrial ganglion. Ventricular myocardium receives projection of neuronal terminals only from the AVG. In this study we tested whether a decrease in N-type Ca channels in AVG neurons contributes to ventricular arrhythmogenesis.
Methods And Results: Lentiviral Ca2.2-α shRNA (2 μL, 2×10 pfu/mL) or scrambled shRNA was in vivo transfected into rat AVG neurons. Nontransfected sham rats served as controls. Using real-time single-cell polymerase chain reaction and reverse-phase protein array, we found that in vivo transfection of Ca2.2-α shRNA decreased expression of Ca2.2-α mRNA and protein in rat AVG neurons. Whole-cell patch-clamp data showed that Ca2.2-α shRNA reduced N-type Ca currents and cell excitability in AVG neurons. The data from telemetry electrocardiographic recording demonstrated that 83% (5 out of 6) of conscious rats with Ca2.2-α shRNA transfection had premature ventricular contractions (<0.05 versus 0% of nontransfected sham rats or scrambled shRNA-transfected rats). Additionally, an index of susceptibility to ventricular arrhythmias, inducibility of ventricular arrhythmias evoked by programmed electrical stimulation, was higher in rats with Ca2.2-α shRNA transfection compared with nontransfected sham rats and scrambled shRNA-transfected rats.
Conclusions: A decrease in N-type Ca channels in AVG neurons attenuates vagal control of ventricular myocardium, thereby initiating ventricular arrhythmias.
Altered leptin signaling and attenuated cardiac vagal activity in rats with type 2 diabetes.
Evans A, Tu H, Li Y, Shabaltiy B, Whitney L, Carpenter K Front Physiol. 2025; 16:1547901.
PMID: 40078371 PMC: 11897569. DOI: 10.3389/fphys.2025.1547901.
Lee C, Nguyen H, Kang S, Jeong S Biomedicines. 2024; 12(8).
PMID: 39200187 PMC: 11351538. DOI: 10.3390/biomedicines12081722.
Song J, Chen Y, Chen Y, Qiu M, Xiang W, Ke B Ren Fail. 2024; 46(1):2343817.
PMID: 38682264 PMC: 11060011. DOI: 10.1080/0886022X.2024.2343817.
Cheng L, Yu L, Zhan X, Tse G, Liu T, Fu H J Cardiovasc Dev Dis. 2023; 10(2).
PMID: 36826567 PMC: 9966694. DOI: 10.3390/jcdd10020071.
Tompkins J, Buckley U, Salavatian S, Shivkumar K, Ardell J Front Synaptic Neurosci. 2022; 14:960458.
PMID: 36147731 PMC: 9488518. DOI: 10.3389/fnsyn.2022.960458.